BIOGAIA AB B O.N.
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more
Market Cap & Net Worth: BIOGAIA AB B O.N. (BGLA)
BIOGAIA AB B O.N. (F:BGLA) has a market capitalization of $1.07 Billion (€1.04 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #8437 globally and #910 in its home market, demonstrating a 5.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIOGAIA AB B O.N.'s stock price €10.56 by its total outstanding shares 98497172 (98.50 Million).
BIOGAIA AB B O.N. Market Cap History: 2015 to 2026
BIOGAIA AB B O.N.'s market capitalization history from 2015 to 2026. Data shows growth from $91.89 Million to $1.07 Billion (26.01% CAGR).
BIOGAIA AB B O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIOGAIA AB B O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BGLA by Market Capitalization
Companies near BIOGAIA AB B O.N. in the global market cap rankings as of March 18, 2026.
Key companies related to BIOGAIA AB B O.N. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
BIOGAIA AB B O.N. Historical Marketcap From 2015 to 2026
Between 2015 and today, BIOGAIA AB B O.N.'s market cap moved from $91.89 Million to $ 1.07 Billion, with a yearly change of 26.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.07 Billion | +9.26% |
| 2025 | €977.18 Million | +0.16% |
| 2024 | €975.66 Million | +119.95% |
| 2023 | €443.58 Million | +43.38% |
| 2022 | €309.38 Million | -4.98% |
| 2021 | €325.60 Million | +3.24% |
| 2020 | €315.37 Million | +36.87% |
| 2019 | €230.41 Million | +59.46% |
| 2018 | €144.49 Million | +19.39% |
| 2017 | €121.02 Million | +16.73% |
| 2016 | €103.67 Million | +12.82% |
| 2015 | €91.89 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BIOGAIA AB B O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.07 Billion USD |
| MoneyControl | $1.07 Billion USD |
| MarketWatch | $1.07 Billion USD |
| marketcap.company | $1.07 Billion USD |
| Reuters | $1.07 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.